Completed
An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers - CA046-006
Aggiornato:
18 febbraio, 2025
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice